| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzoate-CoA ligase activity | 2.84e-05 | 3 | 62 | 2 | GO:0018858 | |
| GeneOntologyMolecularFunction | decanoate-CoA ligase activity | 5.67e-05 | 4 | 62 | 2 | GO:0102391 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 7.04e-05 | 26 | 62 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | MAK NUAK1 PIK3CG PIK3R1 PI4KA PARP2 PKN2 POLQ ERN2 GK5 MAP3K3 | 1.31e-04 | 938 | 62 | 11 | GO:0016772 |
| GeneOntologyMolecularFunction | ligase activity | 2.05e-04 | 174 | 62 | 5 | GO:0016874 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 2.62e-04 | 8 | 62 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 2.79e-04 | 41 | 62 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 3.21e-04 | 709 | 62 | 9 | GO:0016773 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 5.12e-04 | 11 | 62 | 2 | GO:0031956 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 5.12e-04 | 11 | 62 | 2 | GO:0016303 | |
| GeneOntologyMolecularFunction | kinase activity | 5.52e-04 | 764 | 62 | 9 | GO:0016301 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 9.03e-04 | 363 | 62 | 6 | GO:0106310 | |
| GeneOntologyMolecularFunction | polypeptide N-acetylgalactosaminyltransferase activity | 1.74e-03 | 20 | 62 | 2 | GO:0004653 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 1.92e-03 | 21 | 62 | 2 | GO:0016408 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 2.57e-03 | 446 | 62 | 6 | GO:0004674 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 2.85e-03 | 614 | 62 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 2.94e-03 | 26 | 62 | 2 | GO:0015645 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 3.17e-03 | 27 | 62 | 2 | GO:0016405 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 3.17e-04 | 9 | 63 | 2 | GO:0097651 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 3.17e-04 | 9 | 63 | 2 | GO:0005943 | |
| Domain | CPSASE_1 | 1.04e-04 | 5 | 61 | 2 | PS00866 | |
| Domain | CPSASE_2 | 1.56e-04 | 6 | 61 | 2 | PS00867 | |
| Domain | CPSase_L_D2 | 2.18e-04 | 7 | 61 | 2 | PF02786 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 2.18e-04 | 7 | 61 | 2 | IPR005479 | |
| Domain | BC-like_N | 2.18e-04 | 7 | 61 | 2 | IPR005481 | |
| Domain | Biotin_carb_N | 2.18e-04 | 7 | 61 | 2 | PF00289 | |
| Domain | PI3Ka | 3.72e-04 | 9 | 61 | 2 | PF00613 | |
| Domain | - | 3.72e-04 | 9 | 61 | 2 | 1.25.40.70 | |
| Domain | PI3Ka | 3.72e-04 | 9 | 61 | 2 | SM00145 | |
| Domain | PIK_HELICAL | 4.64e-04 | 10 | 61 | 2 | PS51545 | |
| Domain | PI_Kinase | 4.64e-04 | 10 | 61 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 4.64e-04 | 10 | 61 | 2 | IPR001263 | |
| Domain | FAD-dep_OxRdtase | 6.78e-04 | 12 | 61 | 2 | IPR006076 | |
| Domain | DAO | 6.78e-04 | 12 | 61 | 2 | PF01266 | |
| Domain | - | 8.00e-04 | 13 | 61 | 2 | 3.40.50.20 | |
| Domain | ATP-grasp | 9.31e-04 | 14 | 61 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 9.31e-04 | 14 | 61 | 2 | IPR016185 | |
| Domain | ATP_GRASP | 9.31e-04 | 14 | 61 | 2 | PS50975 | |
| Domain | PI3/4_kinase_CS | 1.07e-03 | 15 | 61 | 2 | IPR018936 | |
| Domain | - | 1.07e-03 | 15 | 61 | 2 | 3.30.1490.20 | |
| Domain | - | 1.22e-03 | 16 | 61 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.22e-03 | 16 | 61 | 2 | SM00146 | |
| Domain | AMP-bd_C | 1.38e-03 | 17 | 61 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 1.38e-03 | 17 | 61 | 2 | PF13193 | |
| Domain | PI3/4_kinase_cat_dom | 1.55e-03 | 18 | 61 | 2 | IPR000403 | |
| Domain | ATP_grasp_subdomain_1 | 1.55e-03 | 18 | 61 | 2 | IPR013815 | |
| Domain | PI3_PI4_kinase | 1.55e-03 | 18 | 61 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 1.55e-03 | 18 | 61 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 1.55e-03 | 18 | 61 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.55e-03 | 18 | 61 | 2 | PS00916 | |
| Domain | - | 1.55e-03 | 18 | 61 | 2 | 3.30.470.20 | |
| Domain | Kinase-like_dom | 1.87e-03 | 542 | 61 | 7 | IPR011009 | |
| Domain | Ricin_B_lectin | 3.00e-03 | 25 | 61 | 2 | PF00652 | |
| Domain | AMP-binding_CS | 3.24e-03 | 26 | 61 | 2 | IPR020845 | |
| Domain | RICIN | 3.76e-03 | 28 | 61 | 2 | SM00458 | |
| Domain | AMP_BINDING | 3.76e-03 | 28 | 61 | 2 | PS00455 | |
| Domain | RICIN_B_LECTIN | 3.76e-03 | 28 | 61 | 2 | PS50231 | |
| Domain | AMP-binding | 4.30e-03 | 30 | 61 | 2 | PF00501 | |
| Domain | Ricin_B_lectin | 4.30e-03 | 30 | 61 | 2 | IPR000772 | |
| Domain | AMP-dep_Synth/Lig | 4.30e-03 | 30 | 61 | 2 | IPR000873 | |
| Domain | Glycos_transf_2 | 4.30e-03 | 30 | 61 | 2 | PF00535 | |
| Domain | Glyco_trans_2-like | 4.30e-03 | 30 | 61 | 2 | IPR001173 | |
| Domain | ATP_grasp_subdomain_2 | 4.59e-03 | 31 | 61 | 2 | IPR013816 | |
| Domain | Ser/Thr_kinase_AS | 6.15e-03 | 357 | 61 | 5 | IPR008271 | |
| Domain | S_TKc | 6.29e-03 | 359 | 61 | 5 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 6.51e-03 | 362 | 61 | 5 | PS00108 | |
| Pathway | REACTOME_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE | 1.62e-04 | 6 | 47 | 2 | MM14693 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 2.26e-04 | 7 | 47 | 2 | MM14598 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 3.86e-04 | 9 | 47 | 2 | M22029 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 3.86e-04 | 9 | 47 | 2 | MM1551 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 3.86e-04 | 9 | 47 | 2 | M26968 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 7.03e-04 | 12 | 47 | 2 | M27569 | |
| Pathway | REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ | 7.03e-04 | 12 | 47 | 2 | MM15282 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 7.03e-04 | 12 | 47 | 2 | M27905 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 7.03e-04 | 12 | 47 | 2 | MM15623 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 9.65e-04 | 14 | 47 | 2 | M16884 | |
| Pathway | BIOCARTA_ERK5_PATHWAY | 9.65e-04 | 14 | 47 | 2 | MM1481 | |
| Pathway | WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE | 9.65e-04 | 14 | 47 | 2 | M39840 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 9.65e-04 | 14 | 47 | 2 | MM1485 | |
| Pathway | BIOCARTA_ERK5_PATHWAY | 9.65e-04 | 14 | 47 | 2 | M16811 | |
| Pathway | BIOCARTA_LONGEVITY_PATHWAY | 1.11e-03 | 15 | 47 | 2 | M13158 | |
| Pathway | BIOCARTA_BCELLSURVIVAL_PATHWAY | 1.11e-03 | 15 | 47 | 2 | M4835 | |
| Pathway | BIOCARTA_ARF_PATHWAY | 1.27e-03 | 16 | 47 | 2 | MM1524 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 1.27e-03 | 16 | 47 | 2 | MM1512 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.27e-03 | 16 | 47 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.27e-03 | 16 | 47 | 2 | MM1420 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.43e-03 | 17 | 47 | 2 | M10066 | |
| Pathway | BIOCARTA_BCELLSURVIVAL_PATHWAY | 1.43e-03 | 17 | 47 | 2 | MM1353 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 1.43e-03 | 17 | 47 | 2 | MM15584 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 1.43e-03 | 17 | 47 | 2 | M8353 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.43e-03 | 17 | 47 | 2 | MM1372 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 1.43e-03 | 17 | 47 | 2 | MM1408 | |
| Pathway | BIOCARTA_ARF_PATHWAY | 1.43e-03 | 17 | 47 | 2 | M11358 | |
| Pathway | REACTOME_SIGNALING_BY_ALK | 1.43e-03 | 17 | 47 | 2 | MM14790 | |
| Pathway | BIOCARTA_LONGEVITY_PATHWAY | 1.79e-03 | 19 | 47 | 2 | MM1513 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 1.79e-03 | 19 | 47 | 2 | MM1514 | |
| Pathway | BIOCARTA_PAR1_PATHWAY | 1.79e-03 | 19 | 47 | 2 | M3494 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 1.79e-03 | 19 | 47 | 2 | M6355 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 1.91e-03 | 74 | 47 | 3 | M39857 | |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.98e-03 | 75 | 47 | 3 | M5436 | |
| Pathway | BIOCARTA_EDG1_PATHWAY | 1.99e-03 | 20 | 47 | 2 | MM1456 | |
| Pathway | BIOCARTA_NGF_PATHWAY | 1.99e-03 | 20 | 47 | 2 | M7860 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 2.06e-03 | 76 | 47 | 3 | M9052 | |
| Pathway | REACTOME_PI_METABOLISM | 2.14e-03 | 77 | 47 | 3 | MM14590 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 2.19e-03 | 21 | 47 | 2 | M8601 | |
| Pathway | BIOCARTA_IGF1_PATHWAY | 2.19e-03 | 21 | 47 | 2 | M2623 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 2.19e-03 | 21 | 47 | 2 | MM1390 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 2.19e-03 | 21 | 47 | 2 | MM1463 | |
| Pathway | BIOCARTA_RAS_PATHWAY | 2.19e-03 | 21 | 47 | 2 | MM1464 | |
| Pathway | BIOCARTA_INSULIN_PATHWAY | 2.19e-03 | 21 | 47 | 2 | M765 | |
| Pathway | BIOCARTA_EDG1_PATHWAY | 2.41e-03 | 22 | 47 | 2 | M10579 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 2.41e-03 | 22 | 47 | 2 | M13897 | |
| Pathway | BIOCARTA_IGF1_PATHWAY | 2.41e-03 | 22 | 47 | 2 | MM1409 | |
| Pathway | BIOCARTA_NGF_PATHWAY | 2.41e-03 | 22 | 47 | 2 | MM1440 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 2.41e-03 | 22 | 47 | 2 | M15258 | |
| Pathway | BIOCARTA_RAS_PATHWAY | 2.41e-03 | 22 | 47 | 2 | M17294 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 2.41e-03 | 22 | 47 | 2 | M1467 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 2.63e-03 | 23 | 47 | 2 | MM1480 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 2.63e-03 | 23 | 47 | 2 | MM1424 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 2.63e-03 | 23 | 47 | 2 | M18719 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 2.63e-03 | 23 | 47 | 2 | M7897 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 2.63e-03 | 23 | 47 | 2 | MM14993 | |
| Pathway | REACTOME_PI_METABOLISM | 2.74e-03 | 84 | 47 | 3 | M676 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 2.87e-03 | 24 | 47 | 2 | M11420 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 2.87e-03 | 24 | 47 | 2 | MM1373 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 2.87e-03 | 24 | 47 | 2 | MM1467 | |
| Pathway | BIOCARTA_INSULIN_PATHWAY | 2.87e-03 | 24 | 47 | 2 | MM1425 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 2.87e-03 | 24 | 47 | 2 | M11520 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 2.87e-03 | 24 | 47 | 2 | M15926 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 3.11e-03 | 25 | 47 | 2 | MM1519 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 3.11e-03 | 25 | 47 | 2 | M85 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 3.11e-03 | 25 | 47 | 2 | M1547 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 3.11e-03 | 25 | 47 | 2 | M27865 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 3.36e-03 | 26 | 47 | 2 | MM1371 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 3.49e-03 | 188 | 47 | 4 | MM15828 | |
| Pathway | BIOCARTA_VEGF_PATHWAY | 3.62e-03 | 27 | 47 | 2 | M12975 | |
| Pathway | BIOCARTA_GH_PATHWAY | 3.62e-03 | 27 | 47 | 2 | M9043 | |
| Pubmed | Antidepressant-like effect of valproic acid-Possible involvement of PI3K/Akt/mTOR pathway. | 3.23e-06 | 2 | 63 | 2 | 28408298 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 16521160 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 23143475 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24012746 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 30327473 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 9446654 | ||
| Pubmed | Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions. | 3.23e-06 | 2 | 63 | 2 | 17302605 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 19634011 | ||
| Pubmed | Important roles of PI3Kgamma in osteoclastogenesis and bone homeostasis. | 3.23e-06 | 2 | 63 | 2 | 20616072 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 18245521 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 8313897 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15741161 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 29948332 | ||
| Pubmed | O-GlcNAcylation enhances CPS1 catalytic efficiency for ammonia and promotes ureagenesis. | 3.23e-06 | 2 | 63 | 2 | 36064721 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 16709832 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 10579793 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 16699071 | ||
| Pubmed | Frameshift mutations of OGDH, PPAT and PCCA genes in gastric and colorectal cancers. | 9.68e-06 | 3 | 63 | 2 | 27468871 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 17595318 | ||
| Pubmed | Galpha q inhibits cardiac L-type Ca2+ channels through phosphatidylinositol 3-kinase. | 9.68e-06 | 3 | 63 | 2 | 16186103 | |
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 1.27e-05 | 25 | 63 | 3 | 19373938 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 12594831 | ||
| Pubmed | Mapping and developmental expression analysis of the WD-repeat gene Preb. | 1.93e-05 | 4 | 63 | 2 | 10704286 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 15932879 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 18006698 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 22053215 | ||
| Pubmed | Heat shock cognate protein 70 is essential for Akt signaling in endothelial function. | 1.93e-05 | 4 | 63 | 2 | 20018937 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 17053831 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 20805333 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 32830538 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 18443202 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 30667096 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 17963723 | ||
| Pubmed | IL-6 cytoprotection in hyperoxic acute lung injury occurs via PI3K/Akt-mediated Bax phosphorylation. | 3.22e-05 | 5 | 63 | 2 | 19376889 | |
| Pubmed | DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. | 3.22e-05 | 5 | 63 | 2 | 19903888 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 20200404 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 18374639 | ||
| Pubmed | Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. | 3.22e-05 | 5 | 63 | 2 | 12774123 | |
| Pubmed | CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28. | 3.22e-05 | 5 | 63 | 2 | 9915850 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 25157163 | ||
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 8246987 | ||
| Pubmed | Large-scale investigation of genomic markers for severe periodontitis. | 3.22e-05 | 5 | 63 | 2 | 15490304 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 38514619 | ||
| Pubmed | Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. | 4.82e-05 | 6 | 63 | 2 | 19574958 | |
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 20018188 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 25103499 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 9115297 | ||
| Pubmed | 6.74e-05 | 7 | 63 | 2 | 20167705 | ||
| Pubmed | 6.74e-05 | 7 | 63 | 2 | 23791179 | ||
| Pubmed | 6.74e-05 | 7 | 63 | 2 | 17242350 | ||
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 18246200 | ||
| Pubmed | Regulation of membrane traffic by phosphoinositide 3-kinases. | 8.98e-05 | 8 | 63 | 2 | 16467569 | |
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 11159923 | ||
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 18467332 | ||
| Pubmed | 8.98e-05 | 8 | 63 | 2 | 18437351 | ||
| Pubmed | 9.93e-05 | 132 | 63 | 4 | 22496890 | ||
| Pubmed | 1.15e-04 | 9 | 63 | 2 | 19892838 | ||
| Pubmed | 1.15e-04 | 9 | 63 | 2 | 10571082 | ||
| Pubmed | 1.15e-04 | 9 | 63 | 2 | 15192701 | ||
| Pubmed | Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. | 1.15e-04 | 9 | 63 | 2 | 10871282 | |
| Pubmed | 1.15e-04 | 9 | 63 | 2 | 21765914 | ||
| Pubmed | Role and regulation of PDGFRα signaling in liver development and regeneration. | 1.15e-04 | 9 | 63 | 2 | 23529017 | |
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 9113989 | ||
| Pubmed | The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. | 1.44e-04 | 10 | 63 | 2 | 8636073 | |
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 10614646 | ||
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 37037996 | ||
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 8798481 | ||
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 19889638 | ||
| Pubmed | Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity. | 1.44e-04 | 10 | 63 | 2 | 9247029 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.59e-04 | 281 | 63 | 5 | 28706196 | |
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 26952749 | ||
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 16081599 | ||
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 9708406 | ||
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 10985305 | ||
| Pubmed | Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. | 1.76e-04 | 11 | 63 | 2 | 12584329 | |
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 9808187 | ||
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 25104021 | ||
| Pubmed | 1.76e-04 | 11 | 63 | 2 | 9852579 | ||
| Pubmed | Appl1 is dispensable for Akt signaling in vivo and mouse T-cell development. | 2.11e-04 | 12 | 63 | 2 | 20665729 | |
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 14602571 | ||
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 16514418 | ||
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 19380854 | ||
| Pubmed | A cleft lip and palate gene, Irf6, is involved in osteoblast differentiation of craniofacial bone. | 2.11e-04 | 12 | 63 | 2 | 30684382 | |
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 10208934 | ||
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 12077252 | ||
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 9341793 | ||
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 12551992 | ||
| Pubmed | 2.49e-04 | 13 | 63 | 2 | 23215766 | ||
| Pubmed | 2.49e-04 | 13 | 63 | 2 | 9394803 | ||
| Pubmed | 2.90e-04 | 14 | 63 | 2 | 23419831 | ||
| Pubmed | 2.90e-04 | 14 | 63 | 2 | 17157319 | ||
| Pubmed | 2.90e-04 | 14 | 63 | 2 | 9271679 | ||
| Pubmed | HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex. | 3.34e-04 | 15 | 63 | 2 | 18854243 | |
| Pubmed | 3.34e-04 | 15 | 63 | 2 | 20702582 | ||
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 3.34e-04 | 15 | 63 | 2 | 38871984 | |
| Pubmed | HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45. | 3.81e-04 | 16 | 63 | 2 | 16524887 | |
| Pubmed | 3.81e-04 | 16 | 63 | 2 | 11289809 | ||
| Pubmed | 3.81e-04 | 16 | 63 | 2 | 20019835 | ||
| Pubmed | 3.81e-04 | 16 | 63 | 2 | 21029719 | ||
| Pubmed | 3.81e-04 | 16 | 63 | 2 | 20818790 | ||
| Cytoband | 16q22.1 | 4.79e-04 | 110 | 63 | 3 | 16q22.1 | |
| Cytoband | 16p12.3 | 1.01e-03 | 34 | 63 | 2 | 16p12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 1.74e-03 | 172 | 63 | 3 | chr16p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 2.08e-03 | 183 | 63 | 3 | chr16q22 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 8.84e-04 | 20 | 40 | 2 | 433 | |
| GeneFamily | Acyl-CoA synthetase family | 1.50e-03 | 26 | 40 | 2 | 40 | |
| Coexpression | LU_IL4_SIGNALING | 2.71e-06 | 91 | 63 | 5 | M10558 | |
| Coexpression | WIKMAN_ASBESTOS_LUNG_CANCER_DN | 5.13e-05 | 30 | 63 | 3 | M9729 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 5.49e-05 | 408 | 63 | 7 | M11891 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 6.11e-05 | 415 | 63 | 7 | MM1028 | |
| Coexpression | STK33_UP | 6.46e-05 | 286 | 63 | 6 | M2858 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN | 6.92e-05 | 91 | 63 | 4 | M2154 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD103+ CD11b-, Small Intestine, avg-5 | 5.84e-05 | 72 | 62 | 4 | GSM854246_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2 | 9.26e-05 | 81 | 62 | 4 | GSM538234_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, CD11chi CD11b low CD103+ MHCII+ SiglecF-, Lung, avg-3 | 9.72e-05 | 82 | 62 | 4 | GSM538231_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, MHCII+ CD11c+ CD103+ CD11b, Lung, avg-2 | 1.02e-04 | 83 | 62 | 4 | GSM854241_100 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.50e-07 | 196 | 63 | 6 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-06 | 160 | 63 | 5 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-06 | 168 | 63 | 5 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.27e-06 | 170 | 63 | 5 | 46a81d505de845cc59f80594fce338f7fdb9250f | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.27e-06 | 170 | 63 | 5 | 1a9a0487c35cf3fd5806d1f0f0e91ef0e0b9cd0a | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.27e-06 | 170 | 63 | 5 | 830646815410c47e9bca8c9bae75dfc45c9c9b33 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-06 | 188 | 63 | 5 | 72a1ee136d77c77e44793a512f60b5f7815a073a | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-06 | 188 | 63 | 5 | ecbba19eebba21b986caa99de78ea4245fde3600 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.16e-06 | 189 | 63 | 5 | 440c422369de1c49112d18cf8c506a2a3a81f6ba | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.34e-06 | 190 | 63 | 5 | e0b363f772817cfc6ab425430805c1cddcba23f0 | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 7.53e-06 | 191 | 63 | 5 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | IPF-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 7.53e-06 | 191 | 63 | 5 | 9fda87fb6bc5b8b6c0214ec909ebbc9f3f65319b | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.53e-06 | 191 | 63 | 5 | 09dfad8e1fcaaf94775134796b99e4e3fbb9bf40 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.53e-06 | 191 | 63 | 5 | 03e1ac489e918c7affc1cdc09fb3eb255bcf80e5 | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 7.53e-06 | 191 | 63 | 5 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 7.72e-06 | 192 | 63 | 5 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.92e-06 | 193 | 63 | 5 | 0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.12e-06 | 194 | 63 | 5 | ef30baa19b7aa97b61dea916fc2e0f5cf49848d6 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.12e-06 | 194 | 63 | 5 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.12e-06 | 194 | 63 | 5 | 846b4170544cdf58b536fb7a5fd34b79b0b17993 | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 8.12e-06 | 194 | 63 | 5 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 8.54e-06 | 196 | 63 | 5 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 8.54e-06 | 196 | 63 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 8.75e-06 | 197 | 63 | 5 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 8.75e-06 | 197 | 63 | 5 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.75e-06 | 197 | 63 | 5 | 363ae03310f63a586ba3cea2a59f35d5a335a54e | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.97e-06 | 198 | 63 | 5 | 6a4161680b46b2c12353a693c403b5a4bb3da03f | |
| ToppCell | PCW_13-14-Hematologic_Myeloid|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.97e-06 | 198 | 63 | 5 | d42fce8e547dc97f3cf144ab65483a1b11ace267 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Macroglial-Astrocyte|6m / Sample Type, Dataset, Time_group, and Cell type. | 9.41e-06 | 200 | 63 | 5 | 6ff22adb3007c3c9ef64a05c9dbc1d440bdaee1b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Macroglial|6m / Sample Type, Dataset, Time_group, and Cell type. | 9.41e-06 | 200 | 63 | 5 | 42dc8ed66a021097e703eef2d756607396ca2f56 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.46e-05 | 146 | 63 | 4 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.06e-05 | 156 | 63 | 4 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.06e-05 | 156 | 63 | 4 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 160 | 63 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 160 | 63 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 167 | 63 | 4 | 991a93e1075d562b7391f0689b2f62c1351d48d1 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 167 | 63 | 4 | f22d1471c785b30d096ec5cdc68974e850ed7de0 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.20e-05 | 167 | 63 | 4 | 820472887f43b42ae7e44513ca3d5465fb4f71a7 | |
| ToppCell | facs-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 167 | 63 | 4 | 934905aeaafbc215ec8f6a7903498b0e258b9220 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-05 | 168 | 63 | 4 | 61a5435b27b01ff1a509ea463a6af220c5d2c9b3 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-05 | 168 | 63 | 4 | 99148986aa5628f67d85258c171b254be77a071c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-05 | 168 | 63 | 4 | 26fce414439ccd204e3acb41f2b4f75072df5a26 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-05 | 168 | 63 | 4 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 9.63e-05 | 169 | 63 | 4 | 625788d86f0ceebcf2653a251db1f1a9f9746d29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 9.85e-05 | 170 | 63 | 4 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 170 | 63 | 4 | ece7c20e89c190a7ec68032b6c2efeb458c43f9a | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.85e-05 | 170 | 63 | 4 | 3cbeea6bfa500928c413b1c6129f6dedc769cd1e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 9.85e-05 | 170 | 63 | 4 | 403b6b749d70d845838dcda7daf99971b50792a2 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.85e-05 | 170 | 63 | 4 | 7bba77ae34a0259fad6ee98cf665ff50f77a1328 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.85e-05 | 170 | 63 | 4 | a43b977a7fe745536cf96b7c080397d9fa73086b | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 171 | 63 | 4 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | ILEUM-non-inflamed-(3)_Inf._Macrophages|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.05e-04 | 173 | 63 | 4 | a8db746992a915a8431ac5c155612e89c4af3cad | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-04 | 173 | 63 | 4 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 174 | 63 | 4 | 75b3a852140fb726025c3c987143d67944afde2d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 174 | 63 | 4 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-04 | 175 | 63 | 4 | cd42020fe57afeaadfbd3ef6d7375e66d71e9669 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 176 | 63 | 4 | 98176bf3c961d5262593e2d5d002836adb010e13 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 177 | 63 | 4 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 177 | 63 | 4 | cdad5a2f672a7f07c05669bfcaf1ec74defd3de7 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 177 | 63 | 4 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | ASK428-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.15e-04 | 177 | 63 | 4 | 66074a288501c136b4e83b883db5f0d8269ee326 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 177 | 63 | 4 | 991ae76bb615392d84aeb89886148fa42c1c649c | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.18e-04 | 178 | 63 | 4 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 178 | 63 | 4 | 24e8c62060455159235985f456af0c5023a7f3f5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 178 | 63 | 4 | 4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 179 | 63 | 4 | 4f20540bfbcefe0e83812be7ea542e8bb3bf19bc | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 179 | 63 | 4 | d78eacf47847a50888dd16c35bed9b7afc80010f | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 180 | 63 | 4 | 97241f62ee133dcb0d4855ffda5dd1349de9f7b2 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 180 | 63 | 4 | 41896546cd1cc458e08c0d4e19aa4860e5d4fcd6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-04 | 181 | 63 | 4 | 6771f2c72073c59aab905945a619907b7fd0fd77 | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.28e-04 | 182 | 63 | 4 | 63c3b63315276b66667d49fab09661ac320e7a36 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 182 | 63 | 4 | d5d6bc16458bc665e7ad6669040d79f73f640044 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 182 | 63 | 4 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 182 | 63 | 4 | 0b59ead4bb4486c7ec2ee90b94ee3a09905612c5 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-04 | 182 | 63 | 4 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 182 | 63 | 4 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 183 | 63 | 4 | aed12b743334f3813db0c70d4fe7df90e0673f54 | |
| ToppCell | Dendritic_Cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-04 | 183 | 63 | 4 | dd09e39e8ca282ff0f470e0652d519e190badd0b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 183 | 63 | 4 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 183 | 63 | 4 | 24679153b654c148dbd572e9013c0a6e58718ada | |
| ToppCell | wk_08-11-Hematologic-Myeloid-DC3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 184 | 63 | 4 | 7d9294e5a55964903feda135e5bea0338824ed83 | |
| ToppCell | COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease group, lineage and cell class | 1.34e-04 | 184 | 63 | 4 | ad6e910eaebe841a68a5f2f329d43dafc5db158a | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.34e-04 | 184 | 63 | 4 | 9d678b24532b7763f2e73f7ccb496259977c5204 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.34e-04 | 184 | 63 | 4 | 383374ad17bd322b8d703a22e475d34ca7b2e6b6 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 184 | 63 | 4 | 3d7dd193a0826cc7a4e454a29236a16c315e5965 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.34e-04 | 184 | 63 | 4 | 5535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 184 | 63 | 4 | 45577ff91c3b2b303acd97239dde2463ea7a429c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Dendritic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 185 | 63 | 4 | 0a87d2ee8fffc812224c05a26c729733a5e64d2c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 185 | 63 | 4 | e63fde030be822ebf32143a41f8cc684cb720f5b | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 186 | 63 | 4 | 6575ec6a626cdea169ffd185d47828dfaa29475d | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC2|Liver / Manually curated celltypes from each tissue | 1.39e-04 | 186 | 63 | 4 | 92ef569c8f864d3abaa087cd3ce0366e8f9f50c2 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_dendritic_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 186 | 63 | 4 | fc6e591089c87a66653c8e552be9c0fe0c82ecd5 | |
| ToppCell | Dendritic_Cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-04 | 186 | 63 | 4 | 1d52912bd17e232cf39b2423a4d93585c164ba34 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 186 | 63 | 4 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.42e-04 | 187 | 63 | 4 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.42e-04 | 187 | 63 | 4 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.42e-04 | 187 | 63 | 4 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue | 1.42e-04 | 187 | 63 | 4 | ab9c9930341527122f26fe5544c5c4818d1fd1b5 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-04 | 188 | 63 | 4 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 188 | 63 | 4 | 8fc15c8b78fdd1a578e34325011bc5a87a8aab31 | |
| Disease | X-21319 measurement | 4.20e-06 | 2 | 61 | 2 | EFO_0800807 | |
| Disease | X-11478 measurement | 1.26e-05 | 3 | 61 | 2 | EFO_0021242 | |
| Disease | otosclerosis | 2.44e-05 | 81 | 61 | 4 | EFO_0004213 | |
| Disease | 3-hydroxyhexanoate measurement | 4.19e-05 | 5 | 61 | 2 | EFO_0800378 | |
| Disease | indoleacetoylcarnitine measurement | 6.27e-05 | 6 | 61 | 2 | EFO_0800106 | |
| Disease | glutaroyl carnitine measurement | 3.23e-04 | 13 | 61 | 2 | EFO_0021005 | |
| Disease | body surface area | 3.55e-04 | 643 | 61 | 7 | EFO_0022196 | |
| Disease | diffuse idiopathic skeletal hyperostosis | 4.34e-04 | 15 | 61 | 2 | EFO_0007236 | |
| Disease | cortical thickness | 4.45e-04 | 1113 | 61 | 9 | EFO_0004840 | |
| Disease | carnitine measurement | 5.31e-04 | 76 | 61 | 3 | EFO_0010469 | |
| Disease | glutarylcarnitine (C5-DC) measurement | 5.60e-04 | 17 | 61 | 2 | EFO_0800030 | |
| Disease | Depression, Bipolar | 5.94e-04 | 79 | 61 | 3 | C0005587 | |
| Disease | alanine measurement | 7.61e-04 | 86 | 61 | 3 | EFO_0009765 | |
| Disease | serum homoarginine measurement | 7.80e-04 | 20 | 61 | 2 | EFO_0005421 | |
| Disease | Liver Cirrhosis, Experimental | 1.06e-03 | 774 | 61 | 7 | C0023893 | |
| Disease | response to quetiapine | 1.53e-03 | 28 | 61 | 2 | GO_0097335 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.53e-03 | 28 | 61 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | Glioblastoma Multiforme | 1.59e-03 | 111 | 61 | 3 | C1621958 | |
| Disease | cortical surface area measurement | 1.69e-03 | 1345 | 61 | 9 | EFO_0010736 | |
| Disease | creatinine measurement, glomerular filtration rate | 1.85e-03 | 117 | 61 | 3 | EFO_0004518, EFO_0005208 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKKEIYMHTGNSSTP | 771 | Q4VNC0 | |
| YLKEMSKHTGNPTSS | 281 | P51589 | |
| TSGTSGLPKMAEHSY | 221 | Q08AH3 | |
| GLGHSPSSYVNTKEM | 201 | Q86TY3 | |
| TCSSIHGYPEPKKMS | 156 | P42081 | |
| PASEYTMHLGLKSTG | 1181 | Q9UQB3 | |
| YTDHMKGVNSGKSPG | 226 | Q9Y2P8 | |
| TPGHPKMIYSSSNLK | 781 | Q9P2N5 | |
| YLMKLNSDGSHSKGD | 66 | A0A075B6H9 | |
| KGLGKMAPSSAHFVT | 516 | Q9UGN5 | |
| NSAAKTYVGHPVKMG | 46 | Q14517 | |
| PTSHVYMFKNGSGDS | 21 | Q5XG99 | |
| KDKTLYHPVSGSCMD | 551 | Q86SR1 | |
| DGSPGKYMSHLASCG | 191 | Q76MJ5 | |
| YASTTHLMTGKKVPS | 3846 | Q2LD37 | |
| SKLYGMKDSATSPPS | 3911 | Q2LD37 | |
| FSLEKSKSSGPMYLH | 1386 | Q8IYD8 | |
| KPLHYTTTMTASVGA | 126 | Q96R09 | |
| GITGTSVAYHLSKMG | 51 | Q8NCN5 | |
| YPLSSGMSTISKKSG | 1456 | P42356 | |
| KGMFPGSLAHTTTKV | 1096 | P23471 | |
| DVYPDGFKGHMLTKS | 506 | P05165 | |
| STKMHGDYTLTLRKG | 361 | P27986 | |
| TMKKGPSGYGFNLHS | 156 | O14745 | |
| EDGTKMKGYSFGHPS | 51 | P31327 | |
| PYHSETPAKKMSLSS | 1091 | O15072 | |
| MIHSLSGKKSAIPYG | 86 | O15229 | |
| SPTMAGGLFAVSKKY | 306 | Q8N4A0 | |
| GLIMGTGIESSSHKY | 166 | Q15392 | |
| IKVDGYMGSTSPSRH | 166 | O75417 | |
| GASHSKKPSMGVFKE | 416 | P20794 | |
| FLPHSYIGNSGMSSK | 221 | Q9H2W1 | |
| RKPGYIHSGATTSTM | 676 | Q9Y4J8 | |
| AHPGGYKSSFKEAKM | 416 | Q14314 | |
| ASFMGLKPSTSKYHL | 391 | Q6ZS86 | |
| SGTLTGSHDYPAKKM | 541 | Q7Z7F0 | |
| YASLLFPKGMKSSDG | 3486 | Q8NDH2 | |
| YGRALSMTHGSVKSP | 311 | Q08357 | |
| MSYQGKKSIPHITSD | 1 | Q14194 | |
| GKNERSHMPGTYLTT | 291 | Q9UHY8 | |
| PGYETMKNKDTGHSN | 26 | Q99759 | |
| PSMHLSSKYGPISYK | 306 | Q96L03 | |
| MYGKGKSNSSAVPSD | 1 | P81877 | |
| GPGSSKKYPSLMASN | 231 | Q9UMZ2 | |
| KNKPRSDALMSSYGH | 826 | Q58EX7 | |
| YLKPKDTSMGNSSSG | 156 | Q8IZP6 | |
| LIGKYSQHPDSGMSD | 516 | A1A5C7 | |
| GDSGSHTFPKMKSKF | 626 | Q8IV61 | |
| PSYTLGMKSLHGEFS | 1631 | O43166 | |
| KHSSKYSAGTMDPAL | 526 | O60285 | |
| KMSPSYHQSKGDPTA | 1336 | Q8N3P4 | |
| KGMLHFGSSDISPYA | 3456 | Q9P2P6 | |
| KSYTMLGRHSDDGPV | 71 | Q9UIL4 | |
| MYSNGSSKDRKLHGT | 161 | Q16513 | |
| TSGTSGLPKMAEHSY | 221 | Q68CK6 | |
| FLFVMGTSGKKTSPH | 991 | P48736 | |
| ESGGMYHCHSGSKPT | 46 | Q8IWU4 | |
| STDMLTIGHKYPSKE | 396 | Q6ZVD7 | |
| SSVPTFKSHKGMGLV | 56 | Q06203 | |
| ATGHFMGKKSLEPSS | 51 | P08949 | |
| STIGFYSESGMPTKH | 206 | Q9H920 | |
| YSESGMPTKHLSDSV | 211 | Q9H920 | |
| SSHTLMKGGSTKYWS | 251 | O14788 | |
| SPKGVLVHTASYGMS | 66 | Q92536 | |
| PYKSSSPKLSGAMSS | 1026 | Q9NPG3 | |
| KDGKSLPPSTYMGHF | 131 | Q5SXM2 | |
| GHGTLDNSKSMKPYN | 221 | Q96NK8 |